Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.clindermatol.2020.12.012 http://scihub22266oqcxt.onion/10.1016/j.clindermatol.2020.12.012 33972053!7834280!33972053     free     free     free       Clin+Dermatol 2021 ; 39 (1): 52-55 Nephropedia Template TP {{tp|p=33972053|t=2021. Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What s the evidence?|pdf=|usr=}}{{33972053}} gab.com Text Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What s the evidence JO: Clin Dermatol http://www.kidney.de/pget.php?&tw=1&pmid=33972053 #FOAvip Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, medical professionals have been overwhelmed by questions beyond the infection itself. In dermatology practice, clinicians have been facing difficulties about the management of chronic immune-mediated skin diseases. Issues arose, such as the grade of immunosuppression or immunomodulation, discontinuation or modification of treatment, and initiation of new treatments. In this comprehensive review, we present the current evidence about the course and management of chronic inflammatory dermatoses during the COVID-19 pandemic, focusing on psoriasis, atopic dermatitis, and hidradenitis suppurativa. Twit Text FOAVip Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What s the evidence ????Clin Dermatol http://www.kidney.de/pget.php?&tw=1&pmid=33972053 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33972053 #FOAvip English Wikipedia <ref>{{Cite pmid|33972053}}</ref> Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What s the evidence? #MMPMID33972053 Patsatsi A; Kyriakou A Clin Dermatol 2021[Jan]; 39 (1): 52-55 PMID33972053show ga Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, medical professionals have been overwhelmed by questions beyond the infection itself. In dermatology practice, clinicians have been facing difficulties about the management of chronic immune-mediated skin diseases. Issues arose, such as the grade of immunosuppression or immunomodulation, discontinuation or modification of treatment, and initiation of new treatments. In this comprehensive review, we present the current evidence about the course and management of chronic inflammatory dermatoses during the COVID-19 pandemic, focusing on psoriasis, atopic dermatitis, and hidradenitis suppurativa. |Biological Products/*therapeutic use[MESH] |COVID-19/*epidemiology/prevention & control[MESH] |Chronic Disease[MESH] |Dermatitis, Atopic/*drug therapy/immunology[MESH] |Hidradenitis Suppurativa/*drug therapy/immunology[MESH] |Humans[MESH] |Prognosis[MESH] |Psoriasis/*drug therapy/immunology[MESH]Impact of the COVID-19 pandemic on the course and management of chroni(epmc).pdf DeepDyve Pubget Overpricing